| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $16.49 ▲ +1.66% | Yesterday | $16.22 • 0.00% | Tomorrow's Theravance Biopharma Inc. Ordinary Shares (TBPH) setup is anchored to $16.22 and targets $16.49 (+1.66%). The near-term read is upside; watch $16.65 / $15.79 because daily realized volatility is about 2.76%. |
Tomorrow's Theravance Biopharma Inc. Ordinary Shares (TBPH) setup is anchored to $16.22 and targets $16.49 (+1.66%). The near-term read is upside; watch $16.65 / $15.79 because daily realized volatility is about 2.76%. | ||||
| Week | $16.25 ▲ +0.18% | Last Week | $16.22 • 0.00% | The 7-day Theravance Biopharma Inc. Ordinary Shares model moves from $16.22 to $16.25 (+0.18%). It gives upside momentum context for this stock, so breaks around $16.65 / $15.79 matter more than a single tick. |
The 7-day Theravance Biopharma Inc. Ordinary Shares model moves from $16.22 to $16.25 (+0.18%). It gives upside momentum context for this stock, so breaks around $16.65 / $15.79 matter more than a single tick. | ||||
| Month | $15.84 ▼ -2.34% | Last Month | $16.22 • 0.00% | The 1-month Theravance Biopharma Inc. Ordinary Shares target is $15.84 (-2.34%), compared with the live reference near $16.22. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Theravance Biopharma Inc. Ordinary Shares target is $15.84 (-2.34%), compared with the live reference near $16.22. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $15.23 ▼ -6.10% | Last Year | $16.22 • 0.00% | The 1-year Theravance Biopharma Inc. Ordinary Shares scenario points to $15.23 (-6.10%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Theravance Biopharma Inc. Ordinary Shares scenario points to $15.23 (-6.10%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $13.82 ▼ -14.80% | 5 Years Ago | $16.22 • 0.00% | The 5-year Theravance Biopharma Inc. Ordinary Shares view is $13.82 (-14.80%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Theravance Biopharma Inc. Ordinary Shares view is $13.82 (-14.80%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| RSI 14 | 45.7 | Neutral |
| MACD | 0.04 | Neutral |
| SMA 50 | $16.21 | Mid |
| SMA 200 | $16.21 | Mid |
| EMA 20 | $16.18 | Mid |
| Opening Price | $16.22 | Start Date | 2021-05-17 |
| Day Range | $15.93 – $16.51 | Market Cap | $855.81M |
| Monthly Range | $15.32 – $16.76 | 24h Volume | n/a |
| 90D Range | $15.14 – $16.94 | Circulating | n/a |
| 52W Range | $14.35 – $17.16 | Max Supply | n/a |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.